Information about in vitro diagnostics included in News is intended for disclosure of corporate information. It is not intended to promote or advertise in vitro diagnostics.
Year
- Jul 08, 2026 News Release Notice Concerning the Execution of a Business Alliance Agreement with Craif, Inc.
- Mar 30, 2026 News Release Notice Concerning Revision of Full-Year Earnings Forecast
- Feb 02, 2026 News Release Full-Scale Operation Begins at Fujisan Mishima Factory
- Dec 15, 2025 News Release TAUNS Laboratories, Inc. has Concluded a Capital and Business Alliance Agreement with EMC Healthcare Co., Ltd.
- Nov 27, 2025 News Release Notice Regarding Acquisition of Shares in CLAIRVO TECHNOLOGIES, Inc.(Making it a Subsidiary)
- Nov 14, 2025 News Release TAUNS Laboratories, Inc. has Concluded a Capital and Business Alliance Agreement with ElectraDx, Inc., an Innovative POCT and OTC Medical Diagnostics Company.
- Nov 14, 2025 News Release Notice of Revision of Dividend Forecast
- Jul 14, 2025 News Release Notice Regarding Withdrawal of Application for Change of Market Classification
- Jun 26, 2025 News Release Notice regarding Selection of Our Company’s Shares as Loan Margin Trading Issue
- May 09, 2025 News Release (Update on Disclosed Matters) Notice regarding Application for Change of Market Classification to the Prime Market of the Tokyo Stock Exchange
- Jul 08, 2026 News Release Notice Concerning the Execution of a Business Alliance Agreement with Craif, Inc.
- Mar 30, 2026 News Release Notice Concerning Revision of Full-Year Earnings Forecast
- Feb 02, 2026 News Release Full-Scale Operation Begins at Fujisan Mishima Factory
- Dec 15, 2025 News Release TAUNS Laboratories, Inc. has Concluded a Capital and Business Alliance Agreement with EMC Healthcare Co., Ltd.
- Nov 27, 2025 News Release Notice Regarding Acquisition of Shares in CLAIRVO TECHNOLOGIES, Inc.(Making it a Subsidiary)
- Nov 14, 2025 News Release TAUNS Laboratories, Inc. has Concluded a Capital and Business Alliance Agreement with ElectraDx, Inc., an Innovative POCT and OTC Medical Diagnostics Company.
- Nov 14, 2025 News Release Notice of Revision of Dividend Forecast
- Jul 14, 2025 News Release Notice Regarding Withdrawal of Application for Change of Market Classification
- Jun 26, 2025 News Release Notice regarding Selection of Our Company’s Shares as Loan Margin Trading Issue
- May 09, 2025 News Release (Update on Disclosed Matters) Notice regarding Application for Change of Market Classification to the Prime Market of the Tokyo Stock Exchange
- No posts
